How can we deliver better value for patients?
Speaker: Rhod McKensey, Chief Executive Officer, Honeysuckle Health
At the Chronic Disease Management Summit, we sat down with Rhod McKensey who is the Chief Executive Officer at Honeysuckle Health. He had some interesting insights about the logic for investing in prevention – particularly chronic disease management. He believes that there is a better way that delivers much better value for patients and funders. Hear what Rhod had to say.
00:16 How understanding consumer health needs enables more personalised healthcare with no impact to health insurance costs?
02:05 How value-based healthcare delivers better outcomes and value for patients and funders?
03:11 Why are collaborative partnerships important in preventative programs for chronic disease management?
04:29 Why is data important in enabling peronalised healthcare?
Rhod McKensey, Chief Executive Officer, Honeysuckle Health
Rhod is the Chief Executive Officer of Honeysuckle Health, a joint venture between nib health funds and Cigna, a large international health insurer. Honeysuckle Health was formed in January 2020 with the business purpose of “building better pathways to better health”. Since forming, Honeysuckle Health has built capability in data and advanced analytics, health services contracting and the delivery and optimisation of health management programs. Immediately prior to Honeysuckle Health, Rhod was Group Executive for nib’s Australian Residents Health Insurance business. During his 15 years at nib, Rhod spent 8 years on the board of Private Healthcare Australia, including an 18-month stint as acting Chair. Rhod also played a key role in developing and launching the Whitecoat business which was recently sold to CBA. Prior to nib Rhod worked as a strategic consultant for McKinsey & Company and a foreign exchange trader for Bankers Trust. Rhod is passionate about improving Australia’s healthcare system and three inter-related areas in particular – (1) The application of data and analytics to healthcare; (2) improving transparency on the price and quality of healthcare interventions; and (3) the application of value-based healthcare principles.
About Honeysuckle Health
Honeysuckle Health is a health services and specialist data science company creating better pathways to better health. We do this by understanding our customers current and future health needs, helping them to prevent and manage disease risk and make better treatment decisions.
Founded in December 2019, Honeysuckle Health is a joint venture between nib Group (nib) and Cigna Corporation (Cigna) a global health services company, though operating independently of both.